4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Aquestive Therapeutics, Inc. (AQST) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Warren, United States with about 147 employees. Its market capitalization is roughly $462 million. In the fiscal year ended 2025-12-31, AQST reported $44M in revenue and ($84M) in net income.
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally.
Interactive charts & full statements → Open the AQST valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $44M | $58M | $51M | $48M | — |
| Gross Profit | $26M | $40M | $30M | $28M | — |
| Operating Income (EBIT) | ($71M) | ($31M) | ($15M) | ($42M) | — |
| Net Income | ($84M) | ($44M) | ($8M) | ($54M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $14M | $13M | $13M | $10M | $9M | — |
| Gross Profit | $11M | $7M | $8M | $5M | $5M | — |
| Operating Income (EBIT) | ($4M) | ($29M) | ($12M) | ($11M) | ($19M) | — |
| Net Income | ($8M) | ($32M) | ($15M) | ($14M) | ($23M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $160M | $101M | $57M | $57M | — |
| Total Liabilities | $194M | $162M | $164M | $176M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AQST viewer.
About TickerBase · Data methodology & sources